Orchid Island Capital Operating Cash Flow increased by 0.7% to $48.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 88.6%, from $25.78M to $48.62M. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 11.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.89M | $22.54M | $35.26M | $114.17M | $70.49M | $105.99M | $0.00 | -$2.63M | $15.97M | $35.49M | $45.01M | $19.29M | $17.51M | $25.78M | $18.44M | $27.97M | $48.26M | $48.62M |
| QoQ Change | — | +62.3% | +56.5% | +223.8% | -38.3% | +50.4% | -100.0% | — | +707.3% | +122.3% | +26.8% | -57.1% | -9.2% | +47.2% | -28.5% | +51.7% | +72.5% | +0.7% |
| YoY Change | — | — | — | — | +407.7% | +370.4% | -100.0% | -102.3% | -77.4% | -66.5% | >999% | +20.8% | — | -42.7% | -4.4% | — | +175.5% | +88.6% |